These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1989241)

  • 1. Lipid and lipoprotein abnormalities in children on hemodialysis and after renal transplantation.
    Van Gool S; Van Damme-Lombaerts R; Cobbaert C; Proesmans W; Eggermont E
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1375-7. PubMed ID: 1989241
    [No Abstract]   [Full Text] [Related]  

  • 2. [Abnormalities of lipid metabolism in chronic dialysis patients].
    Fujioka T; Saito E; Yasugi T; Shimizu T
    Nihon Rinsho; 1992 Jan; 50 Suppl():527-34. PubMed ID: 1578734
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipid and apolipoproteins (ApoAI, ApoB, Apo CIII, ApoE) disturbance in hemodialysis (HD) and renal transplant (Tx) patients.
    Janicki K; Solski J; Janicka L; Kimak E; Bednarek-Skublewska A; Stettner S; Molas G
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):459-66. PubMed ID: 16146031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipoprotein(a) and lipids in chronic renal insufficiency and kidney transplant].
    Ochoa-Sosa CA; Mondragón-Rodríguez G; Zamora-González J; Cardoso-Saldaña G; Herrera-Acosta J; Posadas-Romero C
    Rev Invest Clin; 1998; 50(4):301-6. PubMed ID: 9830317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk factors in diabetic patients undergoing continuous ambulatory peritoneal dialysis.
    Babazono T; Miyamae M; Tomonaga O; Omori Y
    Adv Perit Dial; 1996; 12():120-5. PubMed ID: 8865885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lipid metabolism abnormalities and atherosclerosis in patients on maintenance hemodialysis].
    Musiał J; Undas A; Sysło K
    Przegl Lek; 1994; 51(6):264-7. PubMed ID: 7938663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malondialdehyde concentration in the serum of children with chronic renal failure, chronic hemodialysis and kidney transplantation].
    Otting U; Hellmann C
    Z Urol Nephrol; 1990 Mar; 83(3):141-8. PubMed ID: 2356668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperlipidemia in uremic patients in dialysis].
    Docci D; Bilancioni R; Turci F; Baldrati L
    Quad Sclavo Diagn; 1985 Dec; 21(4):424-9. PubMed ID: 3837917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Kidneys and lipids].
    Bagros P; Aparicio M
    Rev Prat; 1992 Feb; 42(4):417-20. PubMed ID: 1604159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Behavior of important serum lipid fractions in chronic hemodialysis patients and following kidney transplantation].
    Luci V; Wichmann T; Giesselmann M; Koall W; Mampel E
    Z Gesamte Inn Med; 1983 Mar; 38(5):153-7. PubMed ID: 6344469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in serum lipid and lipoprotein levels in patients with chronic uremia during hemodialysis treatment].
    László A; Csalánosiné Németh M; Joó I; Kiss E; Havass Z; Szenohradszki P
    Orv Hetil; 1986 May; 127(19):1129-31. PubMed ID: 3714258
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of lipid abnormalities in continuous ambulatory peritoneal dialysis and hemodialysis patients.
    Ong-Ajyooth L; Sirisalee K; Shayakul C; Vareesangthip K; Vasuvattakul S; Vanichakarn S; Nimmannit S; Chirawong P; Ong-Ajyooth S; Nilwarangkur S
    Transplant Proc; 1994 Aug; 26(4):2077-9. PubMed ID: 8066677
    [No Abstract]   [Full Text] [Related]  

  • 13. [Equivalence values of the antioxidative capacity in serum of children with chronic renal failure, chronic hemodialysis and kidney transplantation].
    Otting U; Hellmann C; Popov I; Lewin G
    Z Urol Nephrol; 1990 Apr; 83(4):189-96. PubMed ID: 2378180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe type III hyperlipoproteinemia in two patients maintained on chronic hemodialysis.
    Feussner G; Bommer J; Ziegler R
    Klin Wochenschr; 1990 Jan; 68(2):65-70. PubMed ID: 2319734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
    Kes P; Reiner Z; Brunetta B
    Lijec Vjesn; 2002; 124(11-12):372-7. PubMed ID: 12679979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased susceptibility of LDL to in vitro oxidation in patients on maintenance hemodialysis: effects of fish oil and vitamin E administration.
    Panzetta O; Cominacini L; Garbin U; Fratta Pasini A; Gammaro L; Bianco F; Davoli A; Campagnola M; De Santis A; Pastorino AM
    Clin Nephrol; 1995 Nov; 44(5):303-9. PubMed ID: 8605710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyslipidemia in patients with chronic renal failure and in renal transplant patients.
    Shah B; Nair S; Sirsat RA; Ashavaid TF; Nair KG
    J Postgrad Med; 1994; 40(2):57-60. PubMed ID: 8737552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
    Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
    Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid and lipoprotein metabolism in chronic kidney disease.
    Kaysen GA
    J Ren Nutr; 2009 Jan; 19(1):73-7. PubMed ID: 19121776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol and lipid disturbances in renal disease: the natural history of uremic dyslipidemia and the impact of hemodialysis and continuous ambulatory peritoneal dialysis.
    Avram MM; Fein PA; Antignani A; Mittman N; Mushnick RA; Lustig AR; Lapuz MH; Goldwasser P
    Am J Med; 1989 Nov; 87(5N):55N-60N. PubMed ID: 2486549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.